Close

Aimmune Therapeutics (AIMT): Palisade Trial Completing Enrollment Early Shows Excitement For Therapy - Wedbush

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 4/25/2024

1. META
2. CMG
3. LRCX
4. IBM
5. SPY
6. HCP
7. BSX
8. SNAP
9. PI
10. NOW


Go back to Aimmune Therapeutics (AIMT): Palisade Trial Completing Enrollment Early Shows Excitement For Therapy - Wedbush
AIMSI Technologies (NASDAQ: AIMT) Delayed: 34.49 --0 (-0%)
Previous Close $34.49    52 Week High $27.31 
Open $7.76    52 Week Low $9.77 
Day High $34.49    P/E N/A 
Day Low $34.49    EPS $0.00 
Volume 42,896